Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Archives of Iranian Medicine|February 4, 2024
Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer RegistryAli Ashkbari, Fazel Isapanah Amlashi, Sima Besharat, et al.
European Journal of Pharmacology|June 9, 2022
Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?Mahboubeh Tajaldini, Mohsen Saeedi, Taghi Amiriani, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 18, 2021
Oral Health and Risk of Upper Gastrointestinal Cancers in a Large Prospective Study from a High-risk Region: Golestan Cohort StudyYukiko Yano, Christian C Abnet, Hossein Poustchi, et al.
European Journal of Pharmacology|December 28, 2020
Preconditioning and anti-apoptotic effects of Metformin and Cyclosporine-A in an isolated bile duct-ligated rat heartHamid Reza Moheimani, Taghi Amiriani, Ali Mohammad Alizadeh, et al.
Archives of Iranian Medicine|September 7, 2021
Building a Cancer Biobank in a Low-Resource Setting in Northern Iran: the Golestan Cancer BiobankFatemeh Ghasemi-Kebria, Nastaran Jafari-Delouie, Taghi Amiriani, et al.
International Journal of Cancer|March 21, 2023
Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018Fatemeh Ghasemi-Kebria, Shahryar Semnani, Abdolreza Fazel, et al.
Archives of Iranian Medicine|June 16, 2020
Trends in the Incidence of Stomach Cancer in Golestan Province, a High-risk Area in Northern Iran, 2004-2016Fatemeh Ghasemi-Kebria, Taghi Amiriani, Abdolreza Fazel, et al.
Middle East Journal of Digestive Diseases|May 30, 2014
Gastroesophageal Reflux Disease and overall and Cause-specific Mortality: A Prospective Study of 50000 IndividualsFarhad Islami, Akram Pourshams, Siavosh Nasseri-Moghaddam, et al.
Cancer Epidemiology|June 20, 2020
Recent cancer incidence trends and short-term predictions in Golestan, Iran 2004-2025Gholamreza Roshandel, Jacques Ferlay, Shahryar Semnani, et al.
Journal of Gastroenterology and Hepatology|January 30, 2020
The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairmentHossein Poustchi, Sara Majd Jabbari, Shahin Merat, et al.
Pageof 7